OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2017
(2)
2024
(2)
2021
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
Not available
S-EPMC5559888
|
biostudies-literature
Cite
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.
Not available
S-EPMC6804912
|
biostudies-literature
Cite
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Not available
S-EPMC8084973
|
biostudies-literature
Cite
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
Not available
S-EPMC5455698
|
biostudies-literature
Cite
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress
Not available
S-SCDT-10_1038-S44318-024-00137-X
|
biostudies-other
Cite
An immunohistochemical atlas of necroptotic pathway expression
Not available
S-SCDT-10_1038-S44321-024-00074-6
|
biostudies-other
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets